A Role for the Inflammasome in Spontaneous Labor at Term

American Journal of Reproductive Immunology

Volumn 79, Issue 6, 2018, Pages

  Romero, Roberto ^a,b,c,d,e   Xu, Yi ^a,b,e   Plazyo, Olesya ^a,b,e   Chaemsaithong, Piya ^a,b,e   Chaiworapongsa, Tinnakorn ^a,b,e   Unkel, Ronald ^a,b,e   Than, Nandor Gabor ^a,b,f,g   Chiang, Po Jen ^a,b   Dong, Zhong ^a,b,e   Xu, Zhonghui ^a,b,e   Tarca, Adi L ^a,b,e   Abrahams, Vikki M ^h   Hassan, Sonia S ^a,b,e   Yeo, Lami ^a,b,e   Gomez Lopez, Nardhy ^a,b,e  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b University of Michigan ^*  (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

caspase 1; chorioamniotic membranes; IL 1 ; NLRP3; parturition; sterile inflammation

Indexed keywords

ABSENT IN MELANOMA 2; BETA ACTIN; CASPASE 4; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CELL PROTEIN; CRYOPYRIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; NACHT DOMAIN LEUCINE RICH REPEAT AND PYRIN DOMAIN CONTAINING PROTEIN 1; NACHT DOMAIN LEUCINE RICH REPEAT AND PYRIN DOMAIN CONTAINING PROTEIN 4; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DECIDUA; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS MEMBRANE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABOR; MRNA EXPRESSION LEVEL; OBSTETRIC DELIVERY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLAST; UPREGULATION; ADOLESCENT; AMNION; INFLAMMATION; METABOLISM; PREGNANCY; YOUNG ADULT;

ADOLESCENT; ADULT; AMNION; CASPASE 1; FEMALE; HUMANS; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; LABOR, OBSTETRIC; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; NOD1 SIGNALING ADAPTOR PROTEIN; PREGNANCY; YOUNG ADULT;

EID: 84959873222     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12440     Document Type: Article

References (253)

1. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK: Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006; 11:317–326.
2. Haddad R, Tromp G, Kuivaniemi H, Chaiworapongsa T, Kim YM, Mazor M, Romero R: Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol 2006; 195:394 e321–394 e324.
3. Hassan SS, Romero R, Haddad R, Hendler I, Khalek N, Tromp G, Diamond MP, Sorokin Y, Malone J Jr: The transcriptome of the uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2006; 195:778–786.
4. Romero R, Gotsch F, Pineles B, Kusanovic JP: Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007; 65:S194–S202.
5. Norman JE, Bollapragada S, Yuan M, Nelson SM: Inflammatory pathways in the mechanism of parturition. BMC Pregnancy Childbirth 2007; 7(Suppl. 1):S7.
6. Mittal P, Romero R, Tarca AL, Gonzalez J, Draghici S, Xu Y, Dong Z, Nhan-Chang CL, Chaiworapongsa T, Lye S, Kusanovic JP, Lipovich L, Mazaki-Tovi S, Hassan SS, Mesiano S, Kim CJ: Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term. J Perinat Med 2010; 38:617–643.
7. Romero R, Brody DT, Oyarzun E, Mazor M, Wu YK, Hobbins JC, Durum SK: Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol 1989; 160:1117–1123.
8. Romero R, Parvizi ST, Oyarzun E, Mazor M, Wu YK, Avila C, Athanassiadis AP, Mitchell MD: Amniotic fluid interleukin-1 in spontaneous labor at term. J Reprod Med 1990; 35:235–238.
9. Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB, Dinarello CA: Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992; 27:117–123.
10. Romero R, Sepulveda W, Mazor M, Brandt F, Cotton DB, Dinarello CA, Mitchell MD: The natural interleukin-1 receptor antagonist in term and preterm parturition. Am J Obstet Gynecol 1992; 167:863–872.
11. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J: Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992; 166:1576–1587.
12. Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M: Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993; 5:81–88.
13. Opsjln SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R: Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169:397–404.
14. Romero R, Gomez R, Galasso M, Mazor M, Berry SM, Quintero RA, Cotton DB: The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: the effect of gestational age, fetal gender, and intrauterine infection. Am J Obstet Gynecol 1994; 171:912–921.
15. Andrews WW, Hauth JC, Goldenberg RL, Gomez R, Romero R, Cassell GH: Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol 1995; 173:606–612.
16. Olah KS, Vince GS, Neilson JP, Deniz G, Johnson PM: Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term. J Reprod Immunol 1996; 32:89–98.
17. Maymon E, Ghezzi F, Edwin SS, Mazor M, Yoon BH, Gomez R, Romero R: The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 1999; 181:1142–1148.
18. Bowen JM, Chamley L, Keelan JA, Mitchell MD: Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta 2002; 23:257–273.
19. Kemp B, Winkler M, Maas A, Maul H, Ruck P, Reineke T, Rath W: Cytokine concentrations in the amniotic fluid during parturition at term: correlation to lower uterine segment values and to labor. Acta Obstet Gynecol Scand 2002; 81:938–942.
20. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD: Cytokines, prostaglandins and parturition–a review. Placenta 2003; 24(Suppl. A):S33–S46.
21. Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ, Vaisbuch E, Than NG, Mazaki-Tovi S, Chaiworapongsa T, Mazor M, Yoon BH, Edwin S, Gomez R, Mittal P, Hassan SS, Sharma S: The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008; 21:529–547.
22. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I: Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991; 165:813–820.
23. Romero R, Gomez R, Galasso M, Munoz H, Acosta L, Yoon BH, Svinarich D, Cotton DB: Macrophage inflammatory protein-1 alpha in term and preterm parturition: effect of microbial invasion of the amniotic cavity. Am J Reprod Immunol 1994; 32:108–113.
24. Dudley DJ, Hunter C, Mitchell MD, Varner MW: Elevations of amniotic fluid macrophage inflammatory protein-1 alpha concentrations in women during term and preterm labor. Obstet Gynecol 1996; 87:94–98.
25. Athayde N, Romero R, Maymon E, Gomez R, Pacora P, Araneda H, Yoon BH: A role for the novel cytokine RANTES in pregnancy and parturition. Am J Obstet Gynecol 1999; 181:989–994.
26. Esplin MS, Romero R, Chaiworapongsa T, Kim YM, Edwin S, Gomez R, Gonzalez R, Adashi EY: Amniotic fluid levels of immunoreactive monocyte chemotactic protein-1 increase during term parturition. J Matern Fetal Neonatal Med 2003; 14:51–56.
27. Hamill N, Romero R, Gotsch F, Kusanovic JP, Edwin S, Erez O, Than NG, Mittal P, Espinoza J, Friel LA, Vaisbuch E, Mazaki-Tovi S, Hassan SS: Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection. J Perinat Med 2008; 36:217–227.
28. Yellon SM, Mackler AM, Kirby MA: The role of leukocyte traffic and activation in parturition. J Soc Gynecol Investig 2003; 10:323–338.
29. Unal ER, Cierny JT, Roedner C, Newman R, Goetzl L: Maternal inflammation in spontaneous term labor. Am J Obstet Gynecol 2011; 204:223 e221–223 e225.
30. Cierny JT, Unal ER, Flood P, Rhee KY, Praktish A, Olson TH, Goetzl L: Maternal inflammatory markers and term labor performance. Am J Obstet Gynecol 2014; 210:447 e441–447 e446.
31. Neal JL, Lamp JM, Lowe NK, Gillespie SL, Sinnott LT, McCarthy DO: Differences in inflammatory markers between nulliparous women admitted to hospitals in preactive vs active labor. Am J Obstet Gynecol 2015; 212:68 e61–68 e68.
32. Taniguchi T, Matsuzaki N, Kameda T, Shimoya K, Jo T, Saji F, Tanizawa O: The enhanced production of placental interleukin-1 during labor and intrauterine infection. Am J Obstet Gynecol 1991; 165:131–137.
33. Fidel PL Jr, Romero R, Ramirez M, Cutright J, Edwin SS, LaMarche S, Cotton DB, Mitchell MD: Interleukin-1 receptor antagonist (IL-1ra) production by human amnion, chorion, and decidua. Am J Reprod Immunol 1994; 32:1–7.
34. Dudley DJ, Collmer D, Mitchell MD, Trautman MS: Inflammatory cytokine mRNA in human gestational tissues: implications for term and preterm labor. J Soc Gynecol Investig 1996; 3:328–335.
35. Ammala M, Nyman T, Salmi A, Rutanen EM: The interleukin-1 system in gestational tissues at term: effect of labour. Placenta 1997; 18:717–723.
36. Keelan JA, Marvin KW, Sato TA, Coleman M, McCowan LM, Mitchell MD: Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 1999; 181:1530–1536.
37. Young A, Thomson AJ, Ledingham M, Jordan F, Greer IA, Norman JE: Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term. Biol Reprod 2002; 66:445–449.
38. Lonergan M, Aponso D, Marvin KW, Helliwell RJ, Sato TA, Mitchell MD, Chaiwaropongsa T, Romero R, Keelan JA: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. J Clin Endocrinol Metab 2003; 88:3835–3844.
39. Osman I, Young A, Ledingham MA, Thomson AJ, Jordan F, Greer IA, Norman JE: Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term. Mol Hum Reprod 2003; 9:41–45.
40. Esplin MS, Peltier MR, Hamblin S, Smith S, Fausett MB, Dildy GA, Branch DW, Silver RM, Adashi EY: Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor. Placenta 2005; 26:661–671.
41. Kim GJ, Romero R, Kuivaniemi H, Tromp G, Haddad R, Kim YM, Kim MR, Nien JK, Hong JS, Espinoza J, Santolaya J, Yoon BH, Mazor M, Kim CJ: Expression of bone morphogenetic protein 2 in normal spontaneous labor at term, preterm labor, and preterm premature rupture of membranes. Am J Obstet Gynecol 2005; 193:1137–1143.
42. Kim YM, Romero R, Chaiworapongsa T, Kim GJ, Kim MR, Kuivaniemi H, Tromp G, Espinoza J, Bujold E, Abrahams VM, Mor G: Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol 2004; 191:1346–1355.
43. Koga K, Mor G: Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol 2010; 63:587–600.
44. Koga K, Izumi G, Mor G, Fujii T, Osuga Y: Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy complications. Am J Reprod Immunol 2014; 72:192–205.
45. Stephen GL, Lui S, Hamilton SA, Tower CL, Harris LK, Stevens A, Jones RL: Transcriptomic profiling of human choriodecidua during term labor: inflammation as a key driver of labor. Am J Reprod Immunol 2015; 73:36–55.
46. Gomez-Lopez N, Tong WC, Arenas-Hernandez M, Tanaka S, Hajar O, Olson DM, Taggart MJ, Mitchell BF: Chemotactic activity of gestational tissues through late pregnancy, term labor, and RU486-induced preterm labor in Guinea pigs. Am J Reprod Immunol 2015; 73:341–352.
47. Liggins G: Cervical ripening as an inflammatory reaction. In The Cervix in Pregnancy and Labor: Clinical and Biochemical Investigations. E Ellwood, A Anderson (eds). Edinburgh, Churchill Livingstone, 1981, pp 1–9.
48. Bokstrom H, Brannstrom M, Alexandersson M, Norstrom A: Leukocyte subpopulations in the human uterine cervical stroma at early and term pregnancy. Hum Reprod 1997; 12:586–590.
49. Mackler AM, Iezza G, Akin MR, McMillan P, Yellon SM: Macrophage trafficking in the uterus and cervix precedes parturition in the mouse. Biol Reprod 1999; 61:879–883.
50. Kelly RW: Inflammatory mediators and cervical ripening. J Reprod Immunol 2002; 57:217–224.
51. Sakamoto Y, Moran P, Bulmer JN, Searle RF, Robson SC: Macrophages and not granulocytes are involved in cervical ripening. J Reprod Immunol 2005; 66:161–173.
52. Yellon SM, Ebner CA, Sugimoto Y: Parturition and recruitment of macrophages in cervix of mice lacking the prostaglandin F receptor. Biol Reprod 2008; 78:438–444.
53. Yellon SM, Oshiro BT, Chhaya TY, Lechuga TJ, Dias RM, Burns AE, Force L, Apostolakis EM: Remodeling of the cervix and parturition in mice lacking the progesterone receptor B isoform. Biol Reprod 2011; 85:498–502.
54. Clyde LA, Lechuga TJ, Ebner CA, Burns AE, Kirby MA, Yellon SM: Transection of the pelvic or vagus nerve forestalls ripening of the cervix and delays birth in rats. Biol Reprod 2011; 84:587–594.
55. Payne KJ, Clyde LA, Weldon AJ, Milford TA, Yellon SM: Residency and activation of myeloid cells during remodeling of the prepartum murine cervix. Biol Reprod 2012; 87:106.
56. Myers DA: The recruitment and activation of leukocytes into the immune cervix: further support that cervical remodeling involves an immune and inflammatory mechanism. Biol Reprod 2012; 87:107.
57. Thomson AJ, Telfer JF, Young A, Campbell S, Stewart CJ, Cameron IT, Greer IA, Norman JE: Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod 1999; 14:229–236.
58. Shynlova O, Tsui P, Dorogin A, Lye SJ: Monocyte chemoattractant protein-1 (CCL-2) integrates mechanical and endocrine signals that mediate term and preterm labor. J Immunol 2008; 181:1470–1479.
59. Shynlova O, Tsui P, Jaffer S, Lye SJ: Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour. Eur J Obstet Gynecol Reprod Biol 2009; 144(Suppl. 1):S2–S10.
60. Hamilton S, Oomomian Y, Stephen G, Shynlova O, Tower CL, Garrod A, Lye SJ, Jones RL: Macrophages infiltrate the human and rat decidua during term and preterm labor: evidence that decidual inflammation precedes labor. Biol Reprod 2012; 86:39.
61. Shynlova O, Nedd-Roderique T, Li Y, Dorogin A, Nguyen T, Lye SJ: Infiltration of myeloid cells into decidua is a critical early event in the labour cascade and post-partum uterine remodelling. J Cell Mol Med 2013; 17:311–324.
62. Shynlova O, Lee YH, Srikhajon K, Lye SJ: Physiologic uterine inflammation and labor onset: integration of endocrine and mechanical signals. Reprod Sci 2013; 20:154–167.
63. Arenas-Hernandez M, Romero R, St LD, Hassan SS, Kaye EB, Gomez-Lopez N: An imbalance between innate and adaptive immune cells at the maternal-fetal interface occurs prior to endotoxin-induced preterm birth. Cell Mol Immunol 2015; doi: 10.1038/cmi.2015.22. [Epub ahead of print].
64. Osman I, Young A, Jordan F, Greer IA, Norman JE: Leukocyte density and proinflammatory mediator expression in regional human fetal membranes and decidua before and during labor at term. J Soc Gynecol Investig 2006; 13:97–103.
65. Gomez-Lopez N, Estrada-Gutierrez G, Jimenez-Zamudio L, Vega-Sanchez R, Vadillo-Ortega F: Fetal membranes exhibit selective leukocyte chemotaxic activity during human labor. J Reprod Immunol 2009; 80:122–131.
66. Gomez-Lopez N, Vadillo-Perez L, Hernandez-Carbajal A, Godines-Enriquez M, Olson DM, Vadillo-Ortega F: Specific inflammatory microenvironments in the zones of the fetal membranes at term delivery. Am J Obstet Gynecol 2011; 205:235. e15–24.
67. Gomez-Lopez N, Vadillo-Perez L, Nessim S, Olson DM, Vadillo-Ortega F: Choriodecidua and amnion exhibit selective leukocyte chemotaxis during term human labor. Am J Obstet Gynecol 2011; 204:364.e9–16.
68. Gomez-Lopez N, Vega-Sanchez R, Castillo-Castrejon M, Romero R, Cubeiro-Arreola K, Vadillo-Ortega F: Evidence for a role for the adaptive immune response in human term parturition. Am J Reprod Immunol 2013; 69:212–230.
69. Romero R, Nores J, Mazor M, Sepulveda W, Oyarzun E, Parra M, Insunza A, Montiel F, Behnke E, Cassell GH: Microbial invasion of the amniotic cavity during term labor. Prevalence and clinical significance. J Reprod Med 1993; 38:543–548.
70. Bollapragada S, Youssef R, Jordan F, Greer I, Norman J, Nelson S: Term labor is associated with a core inflammatory response in human fetal membranes, myometrium, and cervix. Am J Obstet Gynecol 2009; 200:104 e101–104 e111.
71. Hassan SS, Romero R, Tarca AL, Nhan-Chang CL, Vaisbuch E, Erez O, Mittal P, Kusanovic JP, Mazaki-Tovi S, Yeo L, Draghici S, Kim JS, Uldbjerg N, Kim CJ: The transcriptome of cervical ripening in human pregnancy before the onset of labor at term: identification of novel molecular functions involved in this process. J Matern Fetal Neonatal Med 2009; 22:1183–1193.
72. Nhan-Chang CL, Romero R, Tarca AL, Mittal P, Kusanovic JP, Erez O, Mazaki-Tovi S, Chaiworapongsa T, Hotra J, Than NG, Kim JS, Hassan SS, Kim CJ: Characterization of the transcriptome of chorioamniotic membranes at the site of rupture in spontaneous labor at term. Am J Obstet Gynecol 2010; 202:462.e1–41.
73. Pineles BL, Romero R, Montenegro D, Tarca AL, Than NG, Hassan S, Gotsch F, Draghici S, Espinoza J, Kim CJ: “The inflammasome” in human parturition. Reprod Sci 2007; 14:59A.
74. Montenegro D, Romero R, Pineles P, Tarca AL, Madsen-Bouterse SA, Hassan S, Kusanovic JP, Draghici S, Espinoza J, Kim CJ: Differential expression of the inflammasome components in the fetal inflammatory response syndrome. Reprod Sci 2007; 14:59A–60A.
75. Gotsch F, Romero R, Chaiworapongsa T, Erez O, Vaisbuch E, Espinoza J, Kusanovic JP, Mittal P, Mazaki-Tovi S, Kim CJ, Kim JS, Edwin S, Nhan-Chang CL, Hamill N, Friel L, Than NG, Mazor M, Yoon BH, Hassan SS: Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturition. J Matern Fetal Neonatal Med 2008; 21:605–616.
76. Martinon F, Burns K, Tschopp J: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10:417–426.
77. Petrilli V, Papin S, Tschopp J: The inflammasome. Curr Biol 2005; 15:R581.
78. Ogura Y, Sutterwala FS, Flavell RA: The inflammasome: first line of the immune response to cell stress. Cell 2006; 126:659–662.
79. Sutterwala FS, Ogura Y, Flavell RA: The inflammasome in pathogen recognition and inflammation. J Leukoc Biol 2007; 82:259–264.
80. Mariathasan S, Monack DM: Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 2007; 7:31–40.
81. Stutz A, Golenbock DT, Latz E: Inflammasomes: too big to miss. J Clin Invest 2009; 119:3502–3511.
82. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009; 10:241–247.
83. Jha S, Ting JP: Inflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseases. J Immunol 2009; 183:7623–7629.
84. Pedra JH, Cassel SL, Sutterwala FS: Sensing pathogens and danger signals by the inflammasome. Curr Opin Immunol 2009; 21:10–16.
85. Lamkanfi M, Dixit VM: Inflammasomes: guardians of cytosolic sanctity. Immunol Rev 2009; 227:95–105.
86. Latz E: The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010; 22:28–33.
87. Schroder K, Tschopp J: The inflammasomes. Cell 2010; 140:821–832.
88. Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G: Inflammasomes as microbial sensors. Eur J Immunol 2010; 40:611–615.
89. Bauernfeind F, Ablasser A, Bartok E, Kim S, Schmid-Burgk J, Cavlar T, Hornung V: Inflammasomes: current understanding and open questions. Cell Mol Life Sci 2011; 68:765–783.
90. Kersse K, Bertrand MJ, Lamkanfi M, Vandenabeele P: NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev 2011; 22:257–276.
91. Gross O, Thomas CJ, Guarda G, Tschopp J: The inflammasome: an integrated view. Immunol Rev 2011; 243:136–151.
92. Lamkanfi M: Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011; 11:213–220.
93. Lamkanfi M, Dixit VM: Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol 2011; 187:597–602.
94. Broz P, Monack DM: Molecular mechanisms of inflammasome activation during microbial infections. Immunol Rev 2011; 243:174–190.
95. Skeldon A, Saleh M: The inflammasomes: molecular effectors of host resistance against bacterial, viral, parasitic, and fungal infections. Front Microbiol 2011; 2:15.
96. Horvath GL, Schrum JE, De Nardo CM, Latz E: Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol Rev 2011; 243:119–135.
97. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA: Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol 2011; 32:110–116.
98. Franchi L, Munoz-Planillo R, Nunez G: Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012; 13:325–332.
99. Dagenais M, Skeldon A, Saleh M: The inflammasome: in memory of Dr. Jurg Tschopp. Cell Death Differ 2012; 19:5–12.
100. Ciraci C, Janczy JR, Sutterwala FS, Cassel SL: Control of innate and adaptive immunity by the inflammasome. Microbes Infect 2012; 14:1263–70.
101. Rathinam VA, Vanaja SK, Fitzgerald KA: Regulation of inflammasome signaling. Nat Immunol 2012; 13:333–342.
102. Franchi L, Nunez G: Immunology. Orchestrating inflammasomes. Science 2012; 337:1299–1300.
103. Henao-Mejia J, Elinav E, Strowig T, Flavell RA: Inflammasomes: far beyond inflammation. Nat Immunol 2012; 13:321–324.
104. Latz E, Xiao TS, Stutz A: Activation and regulation of the inflammasomes. Nat Rev Immunol 2013; 13:397–411.
105. Bauernfeind F, Hornung V: Of inflammasomes and pathogens–sensing of microbes by the inflammasome. EMBO Mol Med 2013; 5:814–826.
106. Vladimer GI, Marty-Roix R, Ghosh S, Weng D, Lien E: Inflammasomes and host defenses against bacterial infections. Curr Opin Microbiol 2013; 16:23–31.
107. Lamkanfi M, Dixit VM: Mechanisms and functions of inflammasomes. Cell 2014; 157:1013–1022.
108. Ulland TK, Ferguson PJ, Sutterwala FS: Evasion of inflammasome activation by microbial pathogens. J Clin Invest 2015; 125:469–477.
109. Vanaja SK, Rathinam VA, Fitzgerald KA: Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol 2015; 25:308–315.
110. Guo H, Callaway JB, Ting JP: Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med 2015; 21:677–687.
111. Black RA, Kronheim SR, Merriam JE, March CJ, Hopp TP: A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta. J Biol Chem 1989; 264:5323–5326.
112. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain NA, Schmidt JA: Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 1989; 86:5227–5231.
113. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al.: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356:768–774.
114. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, et al.: Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992; 256:97–100.
115. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DJ, Su MS: Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997; 275:206–209.
116. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H: Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997; 386:619–623.
117. Dinarello CA: Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 1998; 856:1–11.
118. Fantuzzi G, Dinarello CA: Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol 1999; 19:1–11.
119. Sansonetti PJ, Phalipon A, Arondel J, Thirumalai K, Banerjee S, Akira S, Takeda K, Zychlinsky A: Caspase-1 activation of IL-1beta and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 2000; 12:581–590.
120. Kahlenberg JM, Lundberg KC, Kertesy SB, Qu Y, Dubyak GR: Potentiation of caspase-1 activation by the P2X7 receptor is dependent on TLR signals and requires NF-kappaB-driven protein synthesis. J Immunol 2005; 175:7611–7622.
121. Cayrol C, Girard JP: The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 2009; 106:9021–9026.
122. Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, Brumatti G, Taylor RC, Kersse K, Vandenabeele P, Lavelle EC, Martin SJ: Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009; 31:84–98.
123. Talabot-Ayer D, Lamacchia C, Gabay C, Palmer G: Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 2009; 284:19420–19426.
124. Netea MG, van dVF, van dMJ, Dinarello CA, Joosten LA: Inflammasome-independent regulation of IL-1-family cytokines. Annu Rev Immunol 2015; 33:49–77.
125. Cookson BT, Brennan MA: Pro-inflammatory programmed cell death. Trends Microbiol 2001; 9:113–114.
126. Miao EA, Rajan JV, Aderem A: Caspase-1-induced pyroptotic cell death. Immunol Rev 2011; 243:206–214.
127. Shalini S, Dorstyn L, Dawar S, Kumar S: Old, new and emerging functions of caspases. Cell Death Differ 2015; 22:526–539.
128. Sollberger G, Strittmatter GE, Kistowska M, French LE, Beer HD: Caspase-4 is required for activation of inflammasomes. J Immunol 2012; 188:1992–2000.
129. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J: Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92:501–509.
130. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, Flavell RA, Girardin SE, Godzik A, Harton JA, Hoffman HM, Hugot JP, Inohara N, Mackenzie A, Maltais LJ, Nunez G, Ogura Y, Otten LA, Philpott D, Reed JC, Reith W, Schreiber S, Steimle V, Ward PA: The NLR gene family: a standard nomenclature. Immunity 2008; 28:285–287.
131. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J: NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20:319–325.
132. Sutterwala FS, Flavell RA: NLRC4/IPAF: a CARD carrying member of the NLR family. Clin Immunol 2009; 130:2–6.
133. Qu Y, Misaghi S, Izrael-Tomasevic A, Newton K, Gilmour LL, Lamkanfi M, Louie S, Kayagaki N, Liu J, Komuves L, Cupp JE, Arnott D, Monack D, Dixit VM: Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 2012; 490:539–542.
134. Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B: IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe 2011; 9:363–375.
135. Burckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G, Jahn H, Planyavsky M, Bilban M, Colinge J, Bennett KL, Superti-Furga G: An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 2009; 10:266–272.
136. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES: AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009; 458:509–513.
137. Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, Hardy LL, Garceau V, Sweet MJ, Ross IL, Hume DA, Stacey KJ: HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009; 323:1057–1060.
138. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA: AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458:514–518.
139. Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott E, Eisenlohr L, Landel CP, Alnemri ES: The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010; 11:385–393.
140. Hornung V, Latz E: Intracellular DNA recognition. Nat Rev Immunol 2010; 10:123–130.
141. Franchi L, Nunez G: AIM2 joins the gang of microbial sensors. Cell Host Microbe 2010; 7:340–341.
142. Krieg AM: AIMing 2 defend against intracellular pathogens. Nat Immunol 2010; 11:367–369.
143. Bird L: Innate immunity: ready, AIM, fire!. Nat Rev Immunol 2010; 10:287.
144. Khare S, Luc N, Dorfleutner A, Stehlik C: Inflammasomes and their activation. Crit Rev Immunol 2010; 30:463–487.
145. Koizumi Y, Toma C, Higa N, Nohara T, Nakasone N, Suzuki T: Inflammasome activation via intracellular NLRs triggered by bacterial infection. Cell Microbiol 2012; 14:149–154.
146. Kanneganti TD, Lamkanfi M, Nunez G: Intracellular NOD-like receptors in host defense and disease. Immunity 2007; 27:549–559.
147. Costello MJ, Joyce SK, Abrahams VM: NOD protein expression and function in first trimester trophoblast cells. Am J Reprod Immunol 2007; 57:67–80.
148. Kim YG, Park JH, Shaw MH, Franchi L, Inohara N, Nunez G: The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 2008; 28:246–257.
149. King AE, Horne AW, Hombach-Klonisch S, Mason JI, Critchley HO: Differential expression and regulation of nuclear oligomerization domain proteins NOD1 and NOD2 in human endometrium: a potential role in innate immune protection and menstruation. Mol Hum Reprod 2009; 15:311–319.
150. Mulla MJ, Yu AG, Cardenas I, Guller S, Panda B, Abrahams VM: Regulation of Nod1 and Nod2 in first trimester trophoblast cells. Am J Reprod Immunol 2009; 61:294–302.
151. Franchi L, Warner N, Viani K, Nunez G: Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009; 227:106–128.
152. Cardenas I, Mulla MJ, Myrtolli K, Sfakianaki AK, Norwitz ER, Tadesse S, Guller S, Abrahams VM: Nod1 activation by bacterial iE-DAP induces maternal-fetal inflammation and preterm labor. J Immunol 2011; 187:980–986.
153. Shah A, Hirsch E: TRIF is an essential adaptor protein of TLR3 and NOD2 synergy in macrophages – a role for viral priming in inflammation-induced parturition. Am J Obstet Gynecol 2014; 210:S231–S232.
154. Dinarello CA: Unraveling the NALP-3/IL-1beta inflammasome: a big lesson from a small mutation. Immunity 2004; 20:243–244.
155. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA: IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog 2010; 6:e1000661.
156. Dinarello CA: IL-1: discoveries, controversies and future directions. Eur J Immunol 2010; 40:599–606.
157. Shaw PJ, Lamkanfi M, Kanneganti TD: NOD-like receptor (NLR) signaling beyond the inflammasome. Eur J Immunol 2010; 40:624–627.
158. Garlanda C, Dinarello CA, Mantovani A: The interleukin-1 family: back to the future. Immunity 2013; 39:1003–1018.
159. Conforti-Andreoni C, Beretta O, Licandro G, Qian HL, Urbano M, Vitulli F, Ricciardi-Castagnoli P, Mortellaro A: Synergism of NOD2 and NLRP3 activators promotes a unique transcriptional profile in murine dendritic cells. J Leukoc Biol 2010; 88:1207–1216.
160. von Moltke J, Trinidad NJ, Moayeri M, Kintzer AF, Wang SB, van Rooijen N, Brown CR, Krantz BA, Leppla SH, Gronert K, Vance RE: Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 2012; 490:107–111.
161. Abrahams VM: The role of the Nod-like receptor family in trophoblast innate immune responses. J Reprod Immunol 2011; 88:112–117.
162. Mulla MJ, Myrtolli K, Potter J, Boeras C, Kavathas PB, Sfakianaki AK, Tadesse S, Norwitz ER, Guller S, Abrahams VM: Uric acid induces trophoblast IL-1beta production via the inflammasome: implications for the pathogenesis of preeclampsia. Am J Reprod Immunol 2011; 65:542–548.
163. Mulla MJ, Salmon JE, Chamley LW, Brosens JJ, Boeras CM, Kavathas PB, Abrahams VM: A role for uric acid and the Nalp3 inflammasome in antiphospholipid antibody-induced IL-1beta production by human first trimester trophoblast. PLoS ONE 2013; 8:e65237.
164. Kavathas PB, Boeras CM, Mulla MJ, Abrahams VM: Nod1, but not the ASC inflammasome, contributes to induction of IL-1beta secretion in human trophoblasts after sensing of Chlamydia trachomatis. Mucosal Immunol 2013; 6:235–243.
165. Hoang M, Potter JA, Gysler SM, Han CS, Guller S, Norwitz ER, Abrahams VM: Human fetal membranes generate distinct cytokine profiles in response to bacterial Toll-like receptor and nod-like receptor agonists. Biol Reprod 2014; 90:39.
166. Abrahams VM: Novel mechanisms of placenta inflammation in obstetrics antiphospholipid syndrome. Am J Reprod Immunol 2014; 71:25.
167. Hansen L, Kotla S, Mari G, Rao G: The role of NLRP3 inflammasome in preeclampsia – a translational approach. Am J Obstet Gynecol 2014; 210:S134.
168. Khan RN, Hay DP: A clear and present danger: inflammasomes DAMPing down disorders of pregnancy. Hum Reprod Update 2015; 21:388–405.
169. Pontillo A, Reis EC, Bricher PN, Vianna P, Diniz S, Fernandes KS, Chies JA, Sandrim V: NLRP1 L155H polymorphism is a risk factor for preeclampsia development. Am J Reprod Immunol 2015; 73:577–581.
170. Matias ML, Romao M, Weel IC, Ribeiro VR, Nunes PR, Borges VT, Araujo JP Jr, Peracoli JC, de Oliveira L, Peracoli MT: Endogenous and Uric acid-induced activation of NLRP3 inflammasome in pregnant women with preeclampsia. PLoS ONE 2015; 10:e0129095.
171. Maneta E, Warren AY, Hay DP, Khan RN: Caspase-1-mediated cytokine release from gestational tissues, placental, and cord blood. Front Physiol 2015; 6:186.
172. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES: The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002; 277:21119–21122.
173. Pacora P, Romero R, Maymon E, Gervasi MT, Gomez R, Edwin SS, Yoon BH: Participation of the novel cytokine interleukin 18 in the host response to intra-amniotic infection. Am J Obstet Gynecol 2000; 183:1138–1143.
174. ACOG Practice Bulletin Number 49, December 2003: Dystocia and augmentation of labor. Obstet Gynecol 2003; 102:1445–1454.
175. Redline RW: Placental pathology: a systematic approach with clinical correlations. Placenta 2008; 29(Suppl. A):S86–S91.
176. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM: Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015; 213(4 Suppl):S29–S52.
177. Martinon F, Tschopp J: Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117:561–574.
178. Martinon F, Tschopp J: Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14:10–22.
179. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, Yang XF: Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol 2009; 22:311–322.
180. Sutterwala FS, Ogura Y, Zamboni DS, Roy CR, Flavell RA: NALP3: a key player in caspase-1 activation. J Endotoxin Res 2006; 12:251–256.
181. Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, Katz SI, Kastner DL: Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 2011; 34:755–768.
182. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320:674–677.
183. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS: The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 2008; 105:9035–9040.
184. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008; 9:847–856.
185. Yamasaki K, Muto J, Taylor KR, Cogen AL, Audish D, Bertin J, Grant EP, Coyle AJ, Misaghi A, Hoffman HM, Gallo RL: NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem 2009; 284:12762–12771.
186. Cassel SL, Joly S, Sutterwala FS: The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 2009; 21:194–198.
187. Cassel SL, Sutterwala FS: Sterile inflammatory responses mediated by the NLRP3 inflammasome. Eur J Immunol 2010; 40:607–611.
188. Leemans JC, Cassel SL, Sutterwala FS: Sensing damage by the NLRP3 inflammasome. Immunol Rev 2011; 243:152–162.
189. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237–241.
190. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM: Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440:228–232.
191. Kool M, Petrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, Bergen IM, Castillo R, Lambrecht BN, Tschopp J: Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol 2008; 181:3755–3759.
192. Li H, Willingham SB, Ting JP, Re F: Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol 2008; 181:17–21.
193. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA: Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008; 453:1122–1126.
194. Franchi L, Nunez G: The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol 2008; 38:2085–2089.
195. Demento SL, Eisenbarth SC, Foellmer HG, Platt C, Caplan MJ, Mark Saltzman W, Mellman I, Ledizet M, Fikrig E, Flavell RA, Fahmy TM: Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 2009; 27:3013–3021.
196. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, Choi AM: Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011; 12:222–230.
197. Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler JJ, Knepper-Adrian V, Han R, Qiao L, Eisenbarth SC, Nauseef WM, Cassel SL, Sutterwala FS: Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 2013; 39:311–323.
198. O'Neill LA: Cardiolipin and the Nlrp3 inflammasome. Cell Metab 2013; 18:610–612.
199. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG: Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006; 126:1135–1145.
200. Munoz-Planillo R, Franchi L, Miller LS, Nunez G: A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 2009; 183:3942–3948.
201. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L, Taraporewala ZF, Miller D, Patton JT, Inohara N, Nunez G: Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 2006; 281:36560–36568.
202. Koo IC, Wang C, Raghavan S, Morisaki JH, Cox JS, Brown EJ: ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation during mycobacterial infection. Cell Microbiol 2008; 10:1866–1878.
203. Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ, Tschopp J: The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008; 452:103–107.
204. Thomas PG, Dash P, Aldridge JR Jr, Ellebedy AH, Reynolds C, Funk AJ, Martin WJ, Lamkanfi M, Webby RJ, Boyd KL, Doherty PC, Kanneganti TD: The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009; 30:566–575.
205. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009; 30:556–565.
206. Duncan JA, Gao X, Huang MT, O'Connor BP, Thomas CE, Willingham SB, Bergstralh DT, Jarvis GA, Sparling PF, Ting JP: Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J Immunol 2009; 182:6460–6469.
207. Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS: Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol 2009; 183:3578–3581.
208. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A: Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 2009; 206:79–87.
209. Menu P, Vince JE: The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011; 166:1–15.
210. Rathinam VA, Vanaja SK, Waggoner L, Sokolovska A, Becker C, Stuart LM, Leong JM, Fitzgerald KA: TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 2012; 150:606–619.
211. Clay GM, Sutterwala FS, Wilson ME: NLR proteins and parasitic disease. Immunol Res 2014; 59:142–152.
212. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E: Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009; 183:787–791.
213. Sutterwala FS, Haasken S, Cassel SL: Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci 2014; 1319:82–95.
214. Franchi L, Eigenbrod T, Nunez G: Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 2009; 183:792–796.
215. Lappas M: NOD1 and NOD2 regulate proinflammatory and prolabor mediators in human fetal membranes and myometrium via nuclear factor-kappa B. Biol Reprod 2013; 89:14.
216. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307:731–734.
217. Murray PJ: Beyond peptidoglycan for Nod2. Nat Immunol 2009; 10:1053–1054.
218. Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, Jankowski W, Rosenberg S, Zhang J, Alnemri ES: The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 2007; 14:1590–1604.
219. Lappas M: Caspase-1 activation is increased with human labour in foetal membranes and myometrium and mediates infection-induced interleukin-1beta secretion. Am J Reprod Immunol 2014; 71:189–201.
220. Gomez-Lopez N, Guilbert LJ, Olson DM: Invasion of the leukocytes into the fetal-maternal interface during pregnancy. J Leukoc Biol 2010; 88:625–633.
221. Gomez-Lopez N, StLouis D, Lehr MA, Sanchez-Rodriguez EN, Arenas-Hernandez M: Immune cells in term and preterm labor. Cell Mol Immunol 2014; 11:571–581.
222. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, Dixit VM: Non-canonical inflammasome activation targets caspase-11. Nature 2011; 479:117–121.
223. Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, Dixit VM, Monack DM: Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 2012; 490:288–291.
224. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA, et al.: Structure and mechanism of interleukin-1 beta converting enzyme. Nature 1994; 370:270–275.
225. Dinarello CA: Interleukin-1. Adv Pharmacol 1994; 25:21–51.
226. Dinarello CA: The biological properties of interleukin-1. Eur Cytokine Netw 1994; 5:517–531.
227. Dinarello CA: The interleukin-1 family: 10 years of discovery. FASEB J 1994; 8:1314–1325.
228. Dinarello CA: Interleukin-1. Cytokine Growth Factor Rev 1997; 8:253–265.
229. Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009; 27:519–550.
230. Creagh EM: Caspase crosstalk: integration of apoptotic and innate immune signalling pathways. Trends Immunol 2014; 35:631–640.
231. Romero R, Durum S, Dinarello CA, Oyarzun E, Hobbins JC, Mitchell MD: Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 1989; 37:13–22.
232. Hertelendy F, Romero R, Molnar M, Todd H, Baldassare JJ: Cytokine-initiated signal transduction in human myometrial cells. Am J Reprod Immunol 1993; 30:49–57.
233. Hertelendy F, Rastogi P, Molnar M, Romero R: Interleukin-1beta-induced prostaglandin E2 production in human myometrial cells: role of a pertussis toxin-sensitive component. Am J Reprod Immunol 2001; 45:142–147.
234. Belt AR, Baldassare JJ, Molnar M, Romero R, Hertelendy F: The nuclear transcription factor NF-kappaB mediates interleukin-1beta-induced expression of cyclooxygenase-2 in human myometrial cells. Am J Obstet Gynecol 1999; 181:359–366.
235. Watari M, Watari H, DiSanto ME, Chacko S, Shi GP, Strauss JF 3rd: Pro-inflammatory cytokines induce expression of matrix-metabolizing enzymes in human cervical smooth muscle cells. Am J Pathol 1999; 154:1755–1762.
236. Romero R, Mazor M, Tartakovsky B: Systemic administration of interleukin-1 induces preterm parturition in mice. Am J Obstet Gynecol 1991; 165:969–971.
237. Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ: An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994; 171:1660–1667.
238. Witkin SS, Gravett MG, Haluska GJ, Novy MJ: Induction of interleukin-1 receptor antagonist in rhesus monkeys after intraamniotic infection with group B streptococci or interleukin-1 infusion. Am J Obstet Gynecol 1994; 171:1668–1672.
239. Baggia S, Gravett MG, Witkin SS, Haluska GJ, Novy MJ: Interleukin-1 beta intra-amniotic infusion induces tumor necrosis factor-alpha, prostaglandin production, and preterm contractions in pregnant rhesus monkeys. J Soc Gynecol Investig 1996; 3:121–126.
240. Vadillo-Ortega F, Sadowsky DW, Haluska GJ, Hernandez-Guerrero C, Guevara-Silva R, Gravett MG, Novy MJ: Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1 beta infusion in pregnant rhesus monkeys. Am J Obstet Gynecol 2002; 186:128–138.
241. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ: Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006; 195:1578–1589.
242. Aagaard K, Ganu R, Ma J, Hu M, Miller L, Jobe AH, Kallapur SG, Chougnet CA: Intraamniotic interleukin-1 (IL1β) induces histological chorioamnionitis and alters the microbiome in a primate model of inflammatory preterm birth. Am J Obstet Gynecol 2014; 208:S218.
243. Prince A, Ma J, Miller L, Hu M, Jobe AH, Chougnet CA, Kallapur SG, Aagaard K: Chorioamnionitis induced by intraamniotic injection of IL1, LPS or Ureaplasma parvum is associated with an altered microbiome in a primate model of inflammatory preterm birth. Am J Obstet Gynecol 2014; 212:S153.
244. Presicce P, Senthamaraikannan P, Alvarez M, Rueda CM, Cappelletti M, Miller LA, Jobe AH, Chougnet CA, Kallapur SG: Neutrophil recruitment and activation in decidua with intra-amniotic IL-1beta in the preterm rhesus macaque. Biol Reprod 2015; 92:56.
245. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, et al.: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378:88–91.
246. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Micallef M, Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H, Kurimoto M: Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996; 156:4274–4279.
247. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K, Akira S: Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998; 8:383–390.
248. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Muhl H, Yoon DY, Reznikov LL, Kim SH, Rubinstein M: Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 1998; 63:658–664.
249. Dinarello CA: IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103:11–24.
250. Dinarello CA: Interleukin-18. Methods 1999; 19:121–132.
251. Novick D, Kim S, Kaplanski G, Dinarello CA: Interleukin-18, more than a Th1 cytokine. Semin Immunol 2013; 25:439–448.
252. Dinarello CA, Novick D, Kim S, Kaplanski G: Interleukin-18 and IL-18 binding protein. Front Immunol 2013; 4:289.
253. Jacobsson B, Holst RM, Mattsby-Baltzer I, Nikolaitchouk N, Wennerholm UB, Hagberg H: Interleukin-18 in cervical mucus and amniotic fluid: relationship to microbial invasion of the amniotic fluid, intra-amniotic inflammation and preterm delivery. BJOG 2003; 110:598–603.